Telix Pharmaceuticals Ltd
ASX:TLX

Watchlist Manager
Telix Pharmaceuticals Ltd Logo
Telix Pharmaceuticals Ltd
ASX:TLX
Watchlist
Price: 24.455 AUD -1.67% Market Closed
Market Cap: 8.2B AUD
Have any thoughts about
Telix Pharmaceuticals Ltd?
Write Note

Wall Street
Price Targets

TLX Price Targets Summary
Telix Pharmaceuticals Ltd

Wall Street analysts forecast TLX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TLX is 26.461 AUD with a low forecast of 21.816 AUD and a high forecast of 35.07 AUD.

Lowest
Price Target
21.816 AUD
11% Downside
Average
Price Target
26.461 AUD
8% Upside
Highest
Price Target
35.07 AUD
43% Upside
Telix Pharmaceuticals Ltd Competitors:
Price Targets
002007
Hualan Biological Engineering Inc
20% Upside
4882
Perseus Proteomics Inc
38% Upside
SOBI
Swedish Orphan Biovitrum AB (publ)
23% Upside
LEGN
Legend Biotech Corp
147% Upside
6855
Ascentage Pharma Group International
23% Upside
MIRM
Mirum Pharmaceuticals Inc
54% Upside
VTGN
VistaGen Therapeutics Inc
390% Upside
RPTX
Repare Therapeutics Inc
866% Upside

Revenue
Forecast

Revenue Estimate
Telix Pharmaceuticals Ltd

For the last 5 years the compound annual growth rate for Telix Pharmaceuticals Ltd's revenue is 381%. The projected CAGR for the next 4 years is 32%.

381%
Past Growth
32%
Estimated Growth
Estimates Accuracy
-41%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Telix Pharmaceuticals Ltd

The compound annual growth rate of Telix Pharmaceuticals Ltd's operating income for the next 4 years is 104%.

N/A
Past Growth
104%
Estimated Growth
Estimates Accuracy
29%
Average Beat

Net Income
Forecast

Net Income Estimate
Telix Pharmaceuticals Ltd

The compound annual growth rate of Telix Pharmaceuticals Ltd's net income for the next 4 years is 158%.

N/A
Past Growth
158%
Estimated Growth
Estimates Accuracy
8%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TLX's stock price target?
Price Target
26.461 AUD

According to Wall Street analysts, the average 1-year price target for TLX is 26.461 AUD with a low forecast of 21.816 AUD and a high forecast of 35.07 AUD.

What is Telix Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
32%

For the last 5 years the compound annual growth rate for Telix Pharmaceuticals Ltd's revenue is 381%. The projected CAGR for the next 4 years is 32%.

What is Telix Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
104%

The compound annual growth rate of Telix Pharmaceuticals Ltd's operating income for the next 4 years is 104%.

What is Telix Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
158%

The compound annual growth rate of Telix Pharmaceuticals Ltd's net income for the next 4 years is 158%.

Back to Top